Search terms
Results 1 - 3 of 3 - ordered by :

(1) Principal investigator Dr Satoshi Yasuda of the National Cerebral and Cardiovascular Centre, Suita, Japan said: “This data supports the guideline recommendation to use oral anticoagulant ...

Date : 02/09/2019

Prof. Zannad points out that, “Rivaroxaban is approved at higher doses to treat conditions such as atrial fibrillation (AF) and venous thromboembolism, but in COMMANDER HF, patients were ...

Date : 28/08/2018

The long-term follow-up of patients in the NIPPON (NoborI dual antiplatelet therapy as aPPrOpriate DuratioN) study is presented today at ESC Congress 2017. “These findings support and ...

Date : 28/08/2017